C130H138N28O8 — CID 158164124
N,N-dimethyl-2-(6-methyl-1H-benzimidazol-2-yl)pyridin-3-amine;[2-(6-methyl-1H-benzimidazol-2-yl)-5-(2-piperidin-1-ylethoxy)-3-pyridinyl]methanol;[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;4-[2-[[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]oxy]ethyl]morpholine;[5-methyl-2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;6-methyl-2-[5-(2-piperidin-1-ylethoxy)-2-pyridinyl]-1H-benzimidazole;6-methyl-2-pyridin-2-yl-1H-benzimidazole;(2-pyridin-2-yl-3H-benzimidazol-5-yl)methanol (PubChem CID 158164124) has the molecular formula C130H138N28O8 and a molecular weight of 2220.72 g/mol. Its IUPAC name is N,N-dimethyl-2-(6-methyl-1H-benzimidazol-2-yl)pyridin-3-amine;[2-(6-methyl-1H-benzimidazol-2-yl)-5-(2-piperidin-1-ylethoxy)-3-pyridinyl]methanol;[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;4-[2-[[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]oxy]ethyl]morpholine;[5-methyl-2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;6-methyl-2-[5-(2-piperidin-1-ylethoxy)-2-pyridinyl]-1H-benzimidazole;6-methyl-2-pyridin-2-yl-1H-benzimidazole;(2-pyridin-2-yl-3H-benzimidazol-5-yl)methanol.
| Compound Name | N,N-dimethyl-2-(6-methyl-1H-benzimidazol-2-yl)pyridin-3-amine;[2-(6-methyl-1H-benzimidazol-2-yl)-5-(2-piperidin-1-ylethoxy)-3-pyridinyl]methanol;[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;4-[2-[[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]oxy]ethyl]morpholine;[5-methyl-2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;6-methyl-2-[5-(2-piperidin-1-ylethoxy)-2-pyridinyl]-1H-benzimidazole;6-methyl-2-pyridin-2-yl-1H-benzimidazole;(2-pyridin-2-yl-3H-benzimidazol-5-yl)methanol |
|---|---|
| PubChem CID | 158164124 |
| Molecular Formula | C130H138N28O8 |
| Molecular Weight | 2220.72 g/mol |
| Exact Mass | 2219.13 |
| IUPAC Name | N,N-dimethyl-2-(6-methyl-1H-benzimidazol-2-yl)pyridin-3-amine;[2-(6-methyl-1H-benzimidazol-2-yl)-5-(2-piperidin-1-ylethoxy)-3-pyridinyl]methanol;[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;4-[2-[[2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]oxy]ethyl]morpholine;[5-methyl-2-(6-methyl-1H-benzimidazol-2-yl)-3-pyridinyl]methanol;6-methyl-2-[5-(2-piperidin-1-ylethoxy)-2-pyridinyl]-1H-benzimidazole;6-methyl-2-pyridin-2-yl-1H-benzimidazole;(2-pyridin-2-yl-3H-benzimidazol-5-yl)methanol |
| SMILES | Cc1ccc2nc(-c3ccc(OCCN4CCCCC4)cn3)[nH]c2c1.Cc1ccc2nc(-c3ccccn3)[nH]c2c1.Cc1ccc2nc(-c3ncc(OCCN4CCCCC4)cc3CO)[nH]c2c1.Cc1ccc2nc(-c3ncccc3CO)[nH]c2c1.Cc1ccc2nc(-c3ncccc3N(C)C)[nH]c2c1.Cc1ccc2nc(-c3ncccc3OCCN3CCOCC3)[nH]c2c1.Cc1cnc(-c2nc3ccc(C)cc3[nH]2)c(CO)c1.OCc1ccc2nc(-c3ccccn3)[nH]c2c1 |
| InChI | InChI=1S/C21H26N4O2.C20H24N4O.C19H22N4O2.C15H16N4.C15H15N3O.C14H13N3O.C13H11N3O.C13H11N3/c1-15-5-6-18-19(11-15)24-21(23-18)20-16(14-26)12-17(13-22-20)27-10-9-25-7-3-2-4-8-25;1-15-5-7-17-19(13-15)23-20(22-17)18-8-6-16(14-21-18)25-12-11-24-9-3-2-4-10-24;1-14-4-5-15-16(13-14)22-19(21-15)18-17(3-2-6-20-18)25-12-9-23-7-10-24-11-8-23;1-10-6-7-11-12(9-10)18-15(17-11)14-13(19(2)3)5-4-8-16-14;1-9-3-4-12-13(6-9)18-15(17-12)14-11(8-19)5-10(2)7-16-14;1-9-4-5-11-12(7-9)17-14(16-11)13-10(8-18)3-2-6-15-13;17-8-9-4-5-10-12(7-9)16-13(15-10)11-3-1-2-6-14-11;1-9-5-6-10-12(8-9)16-13(15-10)11-4-2-3-7-14-11/h5-6,11-13,26H,2-4,7-10,14H2,1H3,(H,23,24);5-8,13-14H,2-4,9-12H2,1H3,(H,22,23);2-6,13H,7-12H2,1H3,(H,21,22);4-9H,1-3H3,(H,17,18);3-7,19H,8H2,1-2H3,(H,17,18);2-7,18H,8H2,1H3,(H,16,17);1-7,17H,8H2,(H,15,16);2-8H,1H3,(H,15,16) |
| InChIKey | FWQCKLLPAMCIRA-UHFFFAOYSA-N |
| XLogP | 22.94 |
| TPSA | 463.36 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 166 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2220.72 |
| LogP ≤ 5 | 22.94 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 28 |